Shareholder plans sale of 175 common shares

A shareholder of TWST has filed a Rule 144 notice to sell 175 shares of common stock on the NASDAQ through Fidelity Brokerage Services, with an approximate sale date of February 3, 2026.

Rhea-AI Filing Summary

A shareholder of TWST has filed a Rule 144 notice to sell 175 shares of common stock on the NASDAQ through Fidelity Brokerage Services, with an approximate sale date of February 3, 2026.

The 175 shares were acquired on February 2, 2026 through restricted stock vesting from the issuer as compensation. The filing also lists recent sales for the same seller, including 160 common shares sold on November 3, 2025 for $5,132.70 and 822 common shares sold on November 24, 2025 for $23,599.21. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the TWST Rule 144 filing disclose about upcoming share sales?

The filing shows a TWST shareholder plans to sell 175 common shares. The shares are to be sold on NASDAQ through Fidelity Brokerage Services around February 3, 2026, and were acquired via restricted stock vesting as compensation on February 2, 2026.

How were the 175 TWST common shares in this Rule 144 notice acquired?

The 175 TWST shares were acquired through restricted stock vesting. The shareholder received them from the issuer on February 2, 2026, as compensation rather than a cash purchase, and is now filing notice to resell them under SEC Rule 144.

What recent TWST share sales by the same holder are listed in the filing?

The filing lists several prior TWST common stock sales. Examples include 160 shares sold on November 3, 2025 for $5,132.70 and 822 shares sold on November 24, 2025 for $23,599.21, showing a pattern of relatively small, periodic transactions.

Which broker and exchange are involved in this TWST Rule 144 sale?

The planned TWST share sale will use Fidelity on NASDAQ. The shareholder designated Fidelity Brokerage Services LLC as broker, with the common stock to be sold on the NASDAQ exchange, consistent with typical public-market Rule 144 transactions.

What representation does the selling shareholder make in the TWST Rule 144 form?

The shareholder states they know no undisclosed adverse information. By signing, they represent they are not aware of any material adverse information about the issuer’s current or prospective operations that has not already been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 03:26 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001590947
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Twist Bioscience Corp
SEC File Number	001-38720
Address of Issuer	681 GATEWAY BLVD. SOUTH SAN FRANCISCO CALIFORNIA 94080
Phone	800-719-0671
Name of Person for Whose Account the Securities are To Be Sold	WERNER ROBERT F.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	175	8150.71	61311704	02/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/02/2026	Restricted Stock Vesting	Issuer			175	02/02/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robert F. Werner 681 Gateway Blvd South San Francisco CA 94080	Common	11/03/2025	160	5132.70
Robert F. Werner 681 Gateway Blvd South San Francisco CA 94080	Common	11/21/2025	229	6069.30
Robert F. Werner 681 Gateway Blvd South San Francisco CA 94080	Common	11/24/2025	822	23599.21
Robert F. Werner 681 Gateway Blvd South San Francisco CA 94080	Common	12/08/2025	230	7561.85

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	02/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Robert Werner
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)